JPH0452677Y2 - - Google Patents
Info
- Publication number
- JPH0452677Y2 JPH0452677Y2 JP11581687U JP11581687U JPH0452677Y2 JP H0452677 Y2 JPH0452677 Y2 JP H0452677Y2 JP 11581687 U JP11581687 U JP 11581687U JP 11581687 U JP11581687 U JP 11581687U JP H0452677 Y2 JPH0452677 Y2 JP H0452677Y2
- Authority
- JP
- Japan
- Prior art keywords
- liquid storage
- sample liquid
- cell
- section
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000007788 liquid Substances 0.000 claims description 56
- 210000004027 cell Anatomy 0.000 claims description 22
- 238000005259 measurement Methods 0.000 claims description 16
- 210000000352 storage cell Anatomy 0.000 claims description 11
- 238000004458 analytical method Methods 0.000 claims description 10
- 229920003023 plastic Polymers 0.000 claims description 5
- 125000006850 spacer group Chemical group 0.000 claims description 5
- 239000000523 sample Substances 0.000 description 49
- 239000003153 chemical reaction reagent Substances 0.000 description 18
- 238000012360 testing method Methods 0.000 description 15
- 239000012085 test solution Substances 0.000 description 11
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000005515 coenzyme Substances 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 238000005375 photometry Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 102000034279 3-hydroxybutyrate dehydrogenases Human genes 0.000 description 1
- 108090000124 3-hydroxybutyrate dehydrogenases Proteins 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-L NADH(2-) Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-L 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical class OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
- Optical Measuring Cells (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11581687U JPH0452677Y2 (fr) | 1987-07-30 | 1987-07-30 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11581687U JPH0452677Y2 (fr) | 1987-07-30 | 1987-07-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6421353U JPS6421353U (fr) | 1989-02-02 |
| JPH0452677Y2 true JPH0452677Y2 (fr) | 1992-12-10 |
Family
ID=31357806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11581687U Expired JPH0452677Y2 (fr) | 1987-07-30 | 1987-07-30 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0452677Y2 (fr) |
-
1987
- 1987-07-30 JP JP11581687U patent/JPH0452677Y2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6421353U (fr) | 1989-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Voss et al. | Red cell and plasma cholinesterase activities in microsamples of human and animal blood determined simultaneously by a modified acetylthiocholine/DTNB procedure | |
| CN1914511B (zh) | 血细胞比容和分析物浓度测定 | |
| US4251159A (en) | Disposable multi-chamber cuvette | |
| US3733179A (en) | Method and apparatus for the quantitative determination of blood chemicals in blood derivatives | |
| Kumar et al. | Basic concepts in clinical biochemistry: a practical guide | |
| Coe et al. | Variations in vitreous humor chemical values as a result of instrumentation | |
| Leary et al. | Single stable reagent (Arsenazo III) for optically robust measurement of calcium in serum and plasma | |
| Levinson et al. | Measuring hemoglobin in plasma by reaction with tetramethylbenzidine. | |
| US3890099A (en) | Colorimetric assay for urea | |
| Sykes et al. | Laboratory measurement of bilirubin | |
| JPH0452677Y2 (fr) | ||
| JPS6350743A (ja) | 溶血のある血液試料の分析方法 | |
| Lott et al. | Evaluation of an automated urine chemistry reagent‐strip analyzer | |
| Saibaba et al. | Interferences in clinical chemistry analysis | |
| KINGSLEY et al. | Procedure for serum protein determinations with a triphosphate biuret reagent | |
| Bandi et al. | Extended clinical trial and evaluation of glucose determination with the Eastman Kodak Ektachem GLU/BUN Analyzer. | |
| Saifer et al. | Rapid system of microchemical analysis for the clinical laboratory | |
| JPS5845562A (ja) | 体液中のβ―リポプロテインフラクシヨンの測定法 | |
| US20070196927A1 (en) | Method For Qualitative And/Or Quantitative Detection Of Polyethylene Glycols In Biological Fluids | |
| Costello et al. | Multilayer film analysis: evaluation of ion-selective electrolyte slides. | |
| Landt et al. | Monoject Samplette capillary blood container with serum separator evaluated for collection of specimens for therapeutic drug assays and common clinical-chemical tests. | |
| Haas et al. | Modified DuPont aca calcium method for hemolyzed specimens | |
| Satgunasingam et al. | A simple and rapid one-tube method for the determination of urinary delta-aminolaevulinic acid. | |
| Hicks et al. | A comparison of three desktop chemistry analyzers for the pediatric practice | |
| Nanji et al. | Desktop analysers: quality of results obtained by medical office personnel. |